Fabinshy T.
- Country
- Germany
- Department
- Klinik für Frauenheilkunde und Geburtshilfe
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine or Investigator's Choice Chemotherapy in Patients with FRα-High or FRα-Low Platinum-Resistant Epithelial Ovarian Cancer
- 2022-501606-35-00 – Randomized, multicenter, open-label, Phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRα-high recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after second-line platinum-based chemotherapy plus bevacizumab (GLORIOSA).
Data & Insights
Has run more than one trial at 133 of 310 partner sites.
Specializations
Advanced Ovarian Cancer
The investigator specializes in treating advanced high-grade epithelial ovarian cancer, including conditions affecting the fallopian tubes and primary peritoneal cancer. Their research encompasses innovative therapeutic approaches for newly diagnosed cases, particularly focusing on FIGO stage III-IV presentations.
- Advanced Ovarian Cancer Management
- Platinum-based Therapy Integration
- Maintenance Treatment Strategies
Endometrial Cancer
The investigator has significant expertise in treating recurrent and persistent endometrial cancer. Their work focuses on developing treatment strategies for patients who have undergone platinum-based chemotherapy and immunotherapy, exploring novel therapeutic approaches for advanced cases.
- Recurrent Endometrial Cancer Treatment
- Post-Platinum Therapy Options
- Advanced Disease Management
Vulvar Cancer
The investigator concentrates on treating advanced and metastatic vulvar cancer. Their expertise extends to managing cases that are not amenable to conventional treatments, investigating combination therapy approaches for patients with complex disease presentations.
- Metastatic Disease Treatment
- Advanced Therapeutic Combinations
- Complex Case Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.